COVAD survey 2 long-term outcomes: unmet need and protocol

被引：42

作者：

Fazal, Zoha Zahid ^{[1
]}

Sen, Parikshit ^{[2
]}

Joshi, Mrudula ^{[3
]}

Ravichandran, Naveen ^{[4
]}

Lilleker, James B. ^{[5
,6
]}

Agarwal, Vishwesh ^{[7
]}

Kardes, Sinan ^{[8
]}

Kim, Minchul ^{[9
]}

Day, Jessica ^{[10
,11
,12
]}

Makol, Ashima ^{[13
]}

Milchert, Marcin ^{[14
]}

Gheita, Tamer ^{[15
]}

Salim, Babur ^{[16
]}

Velikova, Tsvetelina ^{[17
]}

Gracia-Ramos, Abraham Edgar ^{[18
]}

Parodis, Ioannis ^{[19
,20
,21
]}

Nikiphorou, Elena ^{[22
,23
]}

Tan, Ai Lyn ^{[24
,25
]}

Chatterjee, Tulika ^{[9
]}

Cavagna, Lorenzo ^{[26
,27
]}

Saavedra, Miguel A. ^{[28
]}

Shinjo, Samuel Katsuyuki ^{[29
]}

Ziade, Nelly ^{[30
,31
]}

Selva-O'Callaghan, Albert ^{[32
]}

Nune, Arvind ^{[33
]}

Knitza, Johannes ^{[34
]}

Kuwana, Masataka ^{[35
]}

Toro Gutierrez, Carlos-Enrique ^{[36
]}

Vinicio Caballero-Uribe, Carlo ^{[37
]}

Dey, Dzifa ^{[38
]}

Distler, Oliver ^{[39
]}

Chinoy, Hector ^{[40
,41
,42
]}

Agarwal, Vikas ^{[4
]}

Aggarwal, Rohit ^{[43
]}

Gupta, Latika ^{[4
,40
,44
,45
]}

机构：

[1] Aga Khan Univ Hosp, Med Coll, Natl Stadium Rd, Karachi 3500, Sindh, Pakistan

[2] Maulana Azad Med Coll, 2 Bahadurshah Zafar Marg, Delhi 110002, India

[3] Byramjee Jeejeebhoy Govt Med Coll & Sassoon Gen H, Pune, Maharashtra, India

[4] Sanjay Gandhi Postgrad Inst Med Sci, Dept Clin Immunol & Rheumatol, Lucknow, Uttar Pradesh, India

[5] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol,Div Musculoskeletal & Dermatol Sci, Ctr Musculoskeletal Res,Sch Biol Sci, Manchester, Lancs, England

[6] Northern Care Alliance NHS Fdn Trust, Manchester Ctr Clin Neurosci, Neurol, Salford, Lancs, England

[7] Mahatma Gandhi Mission Med Coll, Navi Mumbai, Navi Mumbai, Maharashtra, India

[8] Istanbul Univ, Istanbul Fac Med, Dept Med Ecol & Hydroclimatol, TR-34093 Istanbul, Turkey

[9] Univ Illinois Coll Med Peoria, Ctr Outcomes Res, Dept Internal Med, Peoria, IL USA

[10] Royal Melbourne Hosp, Dept Rheumatol, Parkville, Vic 3050, Australia

[11] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia

[12] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia

[13] Mayo Clin, Div Rheumatol, Rochester, MN USA

[14] Pomeranian Med Univ, Dept Internal Med Rheumatol Diabetol Geriatr & Cl, Ul Unii Lubelskiej 1, PL-71252 Szczecin, Poland

[15] Cairo Univ, Kasr Al Ainy Sch Med, Rheumatol Dept, Cairo, Egypt

[16] Fauji Fdn Hosp, Rheumatol Dept, Rawalpindi, Pakistan

[17] Sofia Univ St Kliment Ohridski, Univ Hosp Lozenetz, Med Fac, Dept Clin Immunol, 1 Kozyak Str, Sofia 1407, Bulgaria

[18] Inst Mexicano Seguro Social, Natl Med Ctr, Gen Hosp, Dept Internal Med, Av Jacaranda S-N, Mexico City 02990, DF, Mexico

[19] Karolinska Inst, Dept Med Solna, Div Rheumatol, Stockholm, Sweden

[20] Karolinska Univ Hosp, Stockholm, Sweden

[21] Orebro Univ, Fac Med & Hlth, Dept Rheumatol, Orebro, Sweden

[22] Kings Coll London, Ctr Rheumat Dis, London, England

[23] Kings Coll Hosp London, Rheumatol Dept, London, England

[24] Leeds Teaching Hosp Trust, NIHR Leeds Biomed Res Ctr, Leeds, W Yorkshire, England

[25] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England

[26] Fdn IRCCS Policlin San Matteo, Dept Rheumatol, Pavia, Italy

[27] Univ Pavia, Rheumatol Unit, Dipartimento Med Interna & Terapia Med, Pavia, Italy

[28] IMSS, Ctr Med Nacl La Raza, Dept Reumatol Hosp Especialidades Dr Antonio Frag, Mexico City, DF, Mexico

[29] Univ Sao Paulo, Fac Med FMUSP, Div Rheumatol, Sao Paulo, SP, Brazil

[30] St Joseph Univ, Rheumatol Dept, Beirut, Lebanon

[31] Hotel Dieu France Hosp, Rheumatol Dept, Beirut, Lebanon

[32] Southport & Ormskirk Hosp NHS Trust, Southport PR8 6PN, England

[33] Univ Autonoma Barcelona, Vall dHebron Gen Hosp, Med Dept, Syst Autoimmune Dis Unit, Barcelona, Spain

[34] Friedrich Alexander Univ Erlangen Nurnberg, Univ Klinikum Erlangen, Med Klin Rheumatol & Immunol 3, Ulmenweg 18, D-91054 Erlangen, Germany

[35] Nippon Med Sch, Dept Allergy & Rheumatol, Grad Sch Med, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan

[36] Pontificia Javeriana Univ, Reference Ctr Osteoporosis Rheumatol & Dermatol, Internal Med & Rheumatol, Ubicado Cra 77A 5B 5-96 B, Cali, Colombia

[37] Hosp Univ Norte, Dept Med, Barranquilla, Colombia

[38] Univ Ghana Sch Med & Dent, Coll Hlth Sci, Dept Med & Therapeut, Korle Bu, Accra, Ghana

[39] Univ Zurich, Univ Hosp Zurich, Dept Rheumatol, Zurich, Switzerland

[40] Univ Manchester, Ctr Musculoskeletal Res, Sch Biol Sci, Div Musculoskeletal & Dermatol Sci, Manchester, Lancs, England

[41] Univ Manchester, Manchester Univ NHS Fdn Trust, Natl Inst Hlth Res, Manchester Biomed Res Ctr, Manchester, Lancs, England

[42] Northern Care Alliance NHS Fdn Trust, Salford Royal Hosp, Dept Rheumatol, Salford, Lancs, England

[43] Univ Pittsburgh, Sch Med, Div Rheumatol & Clin Immunol, Pittsburgh, PA USA

[44] Royal Wolverhampton Hosp NHS Trust, Dept Rheumatol, Wolverhampton WV10 0QP, England

[45] Sandwell & West Birmingham Hosp NHS Trust, City Hosp, Birmingham, W Midlands, England

来源：

RHEUMATOLOGY INTERNATIONAL | 2022年 / 42卷 / 12期

关键词：

COVID-19; Registries; Vaccination; Long-term adverse effects; Autoimmune diseases; COVID-19;

D O I：

10.1007/s00296-022-05157-6

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Vaccine hesitancy is considered a major barrier to achieving herd immunity against COVID-19. While multiple alternative and synergistic approaches including heterologous vaccination, booster doses, and antiviral drugs have been developed, equitable vaccine uptake remains the foremost strategy to manage pandemic. Although none of the currently approved vaccines are live-attenuated, several reports of disease flares, waning protection, and acute-onset syndromes have emerged as short-term adverse events after vaccination. Hence, scientific literature falls short when discussing potential long-term effects in vulnerable cohorts. The COVAD-2 survey follows on from the baseline COVAD-1 survey with the aim to collect patient-reported data on the long-term safety and tolerability of COVID-19 vaccines in immune modulation. The e-survey has been extensively pilot-tested and validated with translations into multiple languages. Anticipated results will help improve vaccination efforts and reduce the imminent risks of COVID-19 infection, especially in understudied vulnerable groups.

引用

页码：2151 / 2158

页数：8

共 24 条

[1] Vaccine Development against COVID-19: Study from Pre-Clinical Phases to Clinical Trials and Global Use [J].

Ahmed, Sagheer ;

Khan, Saeed ;

Imran, Imran ;

Al Mughairbi, Fadwa ;

Sheikh, Fahad Sultan ;

Hussain, Javid ;

Khan, Ajmal ;

Al-Harrasi, Ahmed .

VACCINES, 2021, 9 (08)

[2] Covid-19 - Implications for the Health Care System (vol 383, pg 1483, 2020) [J].

Blumenthal, D. .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (17) :1698-1698

[3]

[Anonymous], VACCINES TODAY

[4]

[Anonymous], 2021, Suicide prevention, P1

[5] Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study [J].

Augustin, Max ;

Schommers, Philipp ;

Stecher, Melanie ;

Dewald, Felix ;

Gieselmann, Lutz ;

Gruell, Henning ;

Horn, Carola ;

Vanshylla, Kanika ;

Di Cristanziano, Veronica ;

Osebold, Luise ;

Roventa, Maria ;

Riaz, Toqeer ;

Tschernoster, Nikolai ;

Altmueller, Janine ;

Rose, Leonard ;

Salomon, Susanne ;

Priesner, Vanessa ;

Luers, Jan Christoffer ;

Albus, Christian ;

Rosenkranz, Stephan ;

Gathof, Birgit ;

Faetkenheuer, Gerd ;

Hallek, Michael ;

Klein, Florian ;

Suarez, Isabelle ;

Lehmann, Clara .

LANCET REGIONAL HEALTH-EUROPE, 2021, 6

[6] Patient-Reported Outcomes Measurement Information System (PROMIS): Efficient, standardized tools to measure self-reported health and quality of life [J].

Bevans, Margaret ;

Ross, Alyson ;

Cella, David .

NURSING OUTLOOK, 2014, 62 (05) :339-345

[7]

Chen Y, 2022, Bloomsbury Stud Syst, P1, DOI [10.5040/9781350074972, 10.1109/CASES55004.2022.00007, 10.1109/CACRE54574.2022.9834188, 10.1287/ijoc.2021.1140]

[8] To mix or not to mix? A rapid systematic review of heterologous prime-boost covid-19 vaccination [J].